Old Web
English
Sign In
Acemap
>
authorDetail
>
André Galarneau
André Galarneau
Merck & Co.
Medicine
Anesthesia
Surgery
Physical therapy
Neuromuscular Blockade
4
Papers
120
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade.
2015
Anesthesia & Analgesia
Louis-Philippe Fortier
Dolores M. McKeen
Kim Turner
Étienne de Médicis
Brian Warriner
Philip M. Jones
Alan Chaput
Jean-François Pouliot
André Galarneau
Show All
Source
Cite
Save
Citations (109)
Phase II study of targeted therapy with temozolomide in acute myeloid leukaemia and high‐risk myelodysplastic syndrome patients pre‐screened for low O6‐methylguanine DNA methyltransferase expression
2014
British Journal of Haematology
Joseph Brandwein
Jeannine Kassis
Brian Leber
De Hogge
Kang Howson-Jan
Mark D. Minden
André Galarneau
Jean-François Pouliot
Show All
Source
Cite
Save
Citations (11)
The RECITE study: a prospective, blinded, multi-site study of the incidence and severity of residual neuromuscular blockade in Canada: 9AP6-9
2012
European Journal of Anaesthesiology
Louis-Philippe Fortier
Dolores M. McKeen
Kim Turner
Brian Warriner
R. Curtis
André Galarneau
Show All
Source
Cite
Save
Citations (0)
1